Introduction

 

Colorectal cancer is a well-known and commonly diagnosed condition that affects both men and women, usually at age 50 or above. Cancer of the colon or rectum will be the third most commonly diagnosed type of cancer for both men and women in the United States in 2010. 

Colorectal cancer starts either in the colon or rectum. Because cancer of the colon (colon cancer) and cancer of the rectum (rectal cancer) have many common features they are often simply called "colorectal cancer." Other names for this condition are cancer of the large intestine and cancer of the large bowel.

The colon and rectum are part of the large intestine—a long, thick, winding tube that performs the final steps in digesting food. The colon forms most of the large intestine. It soaks up water and minerals from food, converts food to waste, and allows it to exit the body. The rectum is the last segment of the large intestine. It holds solid waste until it leaves the body through the anus as part of a bowel movement.

Although the exact causes of most colorectal cancers are unknown, certain risk factors have been identified. These include older age, ulcerative colitis (a disease causing inflammation of the colon), and a previous or family history of colorectal cancer. Most colorectal tumors begin as noncancerous (benign) polyps on the wall of the colon or rectum.

This content was last reviewed August 15, 2010 by Dr. Reshma L. Mahtani.
Latest Colorectal Cancer News
Eating fish tied to lower risk of colon polyps

January 31, 2012 — NEW YORK (Reuters Health) - Women who eat about three servings of fish per week have a somewhat lower chance of having polyps found during a routine colonoscopy than women who eat just one serving every two weeks, according to a new study.

Costly US health system delivers uneven care: OECD

November 23, 2011 — WASHINGTON (Reuters) - The U.S. healthcare system is more effective at delivering high costs than quality care, according to a new study that found first-rate treatment for cancer but insufficient primary care for other ailments.

U.S. authorities perplexed by drug shortage spike

October 14, 2011 — WASHINGTON (Reuters) - Two years into an escalating shortage of life-saving cancer drugs, regulators and lawmakers are still unable to identify why it is happening, let alone how to solve the problem.

Select news items provided by Reuters Health